Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
03/01/2021
03/02/2021
03/03/2021
03/04/2021
03/05/2021
Date
139.43
136.33
135.09
129.36
130.63
Last
3942880
4033089
3942577
6235077
3881721
Volume
+1.04% -2.22% -0.91% -4.24% +0.98% Change
Sales 2020
8 985 M 1 383 M 1 383 M
Net income 2020
3 530 M 543 M 543 M
Net Debt 2020
-
-
-
P/E ratio 2020
14,8x
Yield 2020
0,15%
Sales 2021
5 359 M 825 M 825 M
Net income 2021
1 600 M 246 M 246 M
Net Debt 2021
-
-
-
P/E ratio 2021
32,7x
Yield 2021
0,06%
Capitalization
53 547 M 8 244 M 8 243 M
Capi. / Sales 2020
5,96x
Capi. / Sales 2021
9,99x
Nbr of Employees
-
Free-Float
100,0%
BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as...
Notations Surperformance© of BGI Genomics Co., Ltd.
Trading Rating : -
Investor Rating :
All news about BGI GENOMICS CO., LTD.
News in other languages on BGI GENOMICS CO., LTD.
BGI Genomics : Chinese state fund invests in gene firm BGI
Chart BGI GENOMICS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BGI GENOMICS CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
2
Average target price
Last Close Price
130,63
Spread / Highest target
-
Spread / Average Target
-
Spread / Lowest Target
-
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
